Education
About Us
Working with TipRanks
Follow Us
BioNano Genomics Inc (BNGO)
NASDAQ:BNGO
Total Valuation
BioNano Genomics has a market cap or net worth of $13.18M. The enterprise value is $39.10M.
Market Cap$13.18M
Enterprise Value$39.10M
Share Statistics
BioNano Genomics has 3,101,438 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,101,438
Owned by Insiders6.94%
Owned by Institutions3.96%
Financial Efficiency
BioNano Genomics’s return on equity (ROE) is -2.42 and return on invested capital (ROIC) is -115.37%.
Return on Equity (ROE)-2.42
Return on Assets (ROA)-1.08
Return on Invested Capital (ROIC)-115.37%
Return on Capital Employed (ROCE)-1.88
Revenue Per Employee368.53K
Profits Per Employee-2.37M
Employee Count98
Asset Turnover0.17
Inventory Turnover1.16
Valuation Ratios
The current PE Ratio of BioNano Genomics is -16.66. BioNano Genomics’s PEG ratio is -0.34.
PE Ratio-16.66
PS Ratio0.23
PB Ratio40.27
Price to Fair Value40.27
Price to FCF-30.52
Price to Operating Cash Flow-30.94
PEG Ratio-0.34
Income Statement
In the last 12 months, BioNano Genomics had revenue of 36.12M and earned -232.49M in profits. Earnings per share was -6.81.
Revenue36.12M
Gross Profit9.57M
Operating Income-215.25M
Pretax Income-232.43M
Net Income-232.49M
EBITDA-213.60M
Earnings Per Share (EPS)-6.81
Cash Flow
In the last 12 months, operating cash flow was -96.72M and capital expenditures -848.00K, giving a free cash flow of -97.57M billion.
Operating Cash Flow-96.72M
Free Cash Flow-97.57M
Free Cash Flow per Share-31.46
Dividends & Yields
BioNano Genomics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.92
52-Week Price Change-90.88%
50-Day Moving Average3.99
200-Day Moving Average16.84
Relative Strength Index (RSI)55.23
Average Volume (3m)170.82K
Important Dates
BioNano Genomics upcoming earnings date is May 7, 2025, TBA Not Confirmed.
Last Earnings DateMar 31, 2025
Next Earnings DateMay 7, 2025
Ex-Dividend Date―
Financial Position
BioNano Genomics as a current ratio of 1.40, with Debt / Equity ratio of 45.95%
Current Ratio1.40
Quick Ratio1.17
Debt to Market Cap0.02
Net Debt to EBITDA-0.29
Interest Coverage Ratio-42.05
Taxes
In the past 12 months, BioNano Genomics has paid 62.00K in taxes.
Income Tax62.00K
Effective Tax Rate>-0.01
Enterprise Valuation
BioNano Genomics EV to EBITDA ratio is -18.42, with an EV/FCF ratio of -31.01.
EV to Sales108.93
EV to EBITDA-18.42
EV to Free Cash Flow-31.01
EV to Operating Cash Flow-31.43
Balance Sheet
BioNano Genomics has $22.95M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$501.00K billion.
Cash & Marketable Securities$22.95M
Total Debt$0.00
Net Cash-$501.00K
Net Cash Per Share-$0.16
Tangible Book Value Per Share$1.82
Margins
Gross margin is -1.80%, with operating margin of -595.98%, and net profit margin of -643.74%.
Gross Margin-1.80%
Operating Margin-595.98%
Pretax Margin-643.57%
Net Profit Margin-643.74%
EBITDA Margin-591.44%
EBIT Margin-629.39%
Analyst Forecast
The average price target for BioNano Genomics is $7.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$7.00
Price Target Upside62.79% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast-14.79%
EPS Growth Forecast76.94%